跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SUGAMMADEX AMOMED 100 MG/ML DE SOLUCION INYECTABLE - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
SUGAMMADEX AMOMED 100 MG/ML DE SOLUCION INYECTABLE
Approved
STANDARD
SUGAMMADEX AMOMED 100 MG/ML DE SOLUCION INYECTABLE
Aop Orphan Pharmaceuticals Gmbh
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Apr 13, 2023
Approval ID
98a1888d508f2df0
Company
Aop Orphan Pharmaceuticals Gmbh
Type
Standard
Approval Details
Approval Id
98a1888d508f2df0
Drug Cima Aemps Name
SUGAMMADEX AMOMED 100 MG/ML DE SOLUCION INYECTABLE
Register Number
1221708001
Holder Company Name
Aop Orphan Pharmaceuticals Gmbh
Marketing Company Name
Aop Orphan Pharmaceuticals Iberia, S.L.U
Holder Company Detail Path
/organization/aop-orphan-pharmaceuticals-gmbh
Authorization Date
2023-04-13
Dosage Form
SOLUCIÓN INYECTABLE
Dose
100 MG/ML
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Aop Orphan Pharmaceuticals Gmbh
Company Detail Path
/organization/aop-orphan-pharmaceuticals-gmbh
Company Information
Pharmaceutical Company Name
AOP Orphan Pharmaceuticals GmbH
Country Name
Austria
City Name
wien,wien,country_at
Address
Leopold Ungar Platz 2
Website
http://www.aoporphan.com
Active Ingredients
SUGAMMADEX SODIO
217,6 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Apr 13, 2023
Approval ID
98a1888d508f2df0
Type
Standard
Back to CIMA-AEMPS Approvals
